Effects of Semaglutide and Tirzepatide on Bone Metabolism in Type 2 Diabetic Mice.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Effects of Semaglutide and Tirzepatide on Bone Metabolism in Type 2 Diabetic Mice.
- Published In:
- Pharmaceuticals (Basel, Switzerland), 17(12) (2024)
- Authors:
- Lv, Fang(2), Cai, Xiaoling(3), Lin, Chu(4), Yang, Wenjia, Ji, Linong
- Database ID:
- RPEP-08783
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08783APA
Lv, Fang; Cai, Xiaoling; Lin, Chu; Yang, Wenjia; Ji, Linong. (2024). Effects of Semaglutide and Tirzepatide on Bone Metabolism in Type 2 Diabetic Mice.. Pharmaceuticals (Basel, Switzerland), 17(12). https://doi.org/10.3390/ph17121655
MLA
Lv, Fang, et al. "Effects of Semaglutide and Tirzepatide on Bone Metabolism in Type 2 Diabetic Mice.." Pharmaceuticals (Basel, 2024. https://doi.org/10.3390/ph17121655
RethinkPeptides
RethinkPeptides Research Database. "Effects of Semaglutide and Tirzepatide on Bone Metabolism in..." RPEP-08783. Retrieved from https://rethinkpeptides.com/research/lv-2024-effects-of-semaglutide-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.